Palatin Technologies

Palatin Technologies EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Palatin Technologies (PTN) as of Nov 4, 2026 is -8.67 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -17.46 M USD — a change of -50.35% (higher).

EBITDA

-8.67 MUSD

YoY

-50.35%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Palatin Technologies is 2026 -8.67 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Palatin Technologies was 2025 -17.46 M USD. It decreases by -50.35% higher compared to the previous year.

The Palatin Technologies EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
35.74 M USD
Jan 1, 2020
-23.61 M USD
Jan 1, 2021
-33.57 M USD
Jan 1, 2022
-36.59 M USD
Jan 1, 2023
-32.46 M USD
Jan 1, 2024
-29.72 M USD
Jan 1, 2025
-17.46 M USD
Jan 1, 2026
-8.67 M USD
The Palatin Technologies EBITDA history
YEAREBITDAYoY
-8.67 MUSD-50.35%
-17.46 MUSD-41.25%
-29.72 MUSD-8.44%
-32.46 MUSD-11.29%
-36.59 MUSD+8.98%
-33.57 MUSD+42.22%
-23.61 MUSD-166.04%
35.74 MUSD+37.87%
25.93 MUSD-345.30%
-10.57 MUSD-78.54%
-49.25 MUSD+184.91%
-17.29 MUSD+9.49%
-15.79 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Palatin Technologies Stock analysis

What does Palatin Technologies do? Palatin Technologies Inc., based in Cranbury, New Jersey, is a biopharmaceutical company focused on developing receptor-specific therapeutics targeting unmet medical needs. The company specializes in molecules that modulate melanocortin and natriuretic peptide receptor systems, aiming to treat conditions such as cardiovascular diseases, fibrotic disorders, and metabolic issues. With 20 employees, it operates within the Health Care sector, listed on the market since 1999. Palatin Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Palatin Technologies stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Palatin Technologies is -8.67 M USD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Palatin Technologies changed from -17.46 M USD to -8.67 M USD, representing a -50.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Palatin Technologies since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Palatin Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Palatin Technologies

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Palatin Technologies